Effectiveness of Exercise Therapy Versus Spinal Manual Therapy in Patients With PFPS

Sponsor
Vrije Universiteit Brussel (Other)
Overall Status
Completed
CT.gov ID
NCT04748692
Collaborator
VU University of Amsterdam (Other)
43
2
51.9

Study Details

Study Description

Brief Summary

Preliminary results of a pilot study in The Bergman Clinic Naarden (NL) show that a local exercise therapy group may decrease pain by 30% on the visual analogue scale (VAS) after 6 weeks. A reduction of 50% on the VAS was realized in a spinal manual therapy group. Therefore, the aim of this study is to compare the effectiveness of local exercise therapy versus spinal manual therapy in patients with PFPS after 6 weeks of intervention and at 6 weeks of follow-up. To the knowledge of the authors, the clinical effectiveness of spinal manual manipulations on pain, function and strength has not been investigated in the medium term.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Local exercise therapy
  • Procedure: Spinal manual therapy
N/A

Detailed Description

Interventions

The local exercise therapy group will focus on strengthening knee and hip muscles three times a week for 6 weeks. Once a week, patients will train with the support of a physiotherapist. The physiotherapist gradually increases the intensity of the exercises improving muscle endurance. The exercises will be supplemented with mobilisations of the patellofemoral joint. Twice a week, patients train at home following a prescribed exercise program writing down their work-out in an exercise journal.

The spinal manual therapy group will be treated one a week for 6 weeks. Before the first intervention an experienced manual therapist performed a clinical examination of the lower back, SIJ, hip and knee. Anatomical maps showing innervation areas of spinal nerve roots will be used to explain the regional interdependence model in the treatment of anterior knee pain. Manual therapy treatment will include manipulations of the thoracolumbar (T12-L3) region or SIJ as well as hip joint. Manipulation will be conducted if a restriction of range of motion will be found in any of the regions. Patients will also be asked to do home exercises focusing on mobilizing the thoracolumbar region and to write down their performance in an exercise journal.

The allocation of the patients to their treatment group will be concealed from the researcher that assesses the outcome measures.

Outcome measures The following baseline characteristics will be self-reported: age (in years), weight (in kg), height (in cm), duration of symptoms (in months), weekly participation in sport (yes/no), previously receiving exercise therapy treatment for the knee (yes/no). Patellofemoral chondral lesions will be graded using the Kellgren and Lawrence system for classification of osteoarthritis (grade 0 = definite absence of X-ray changes of osteoarthritis, grade 1 = doubtful joint space narrowing and possible osteophytic lipping, grade 2 = definite osteophytes and possible joint space narrowing).

Knee pain, functionality and force will be measured using validated measurement instruments. Pain and functionality will be our primary outcomes. Maximum, minimum and current pain intensity will be indicated on a 0-100 mm VAS line. Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100. Our secondary outcome, maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings. Patients will be assessed before intervention (=baseline), at 6 weeks (=immediately after the last intervention) and at 12 weeks (=6 weeks after the last intervention).

Study Design

Study Type:
Interventional
Actual Enrollment :
43 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study is a randomized controlled trial with a follow-up of 6 weeks. Patients with PFPS will be randomly assigned to one of two intervention groups using an online computer-based pseudo-random number generator on which the numbers were generated by use of a complex algorithm (seeded by the computer's clock). The flow diagram of the progress through the phases of the parallel randomised trial of both intervention groups (that is, enrolment, allocation, follow-up, and data analysis) follows the PRISMA statement.This study is a randomized controlled trial with a follow-up of 6 weeks. Patients with PFPS will be randomly assigned to one of two intervention groups using an online computer-based pseudo-random number generator on which the numbers were generated by use of a complex algorithm (seeded by the computer's clock). The flow diagram of the progress through the phases of the parallel randomised trial of both intervention groups (that is, enrolment, allocation, follow-up, and data analysis) follows the PRISMA statement.
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The allocation of the patients to their treatment group will be concealed from the researcher that assesses the outcome measures.
Primary Purpose:
Treatment
Official Title:
Effectiveness of Exercise Therapy Versus Spinal Manual Therapy in Patients With Patellofemoral Pain Syndrome: Medium Term Follow-up Results of a Randomised Controlled Trial
Actual Study Start Date :
Oct 1, 2016
Actual Primary Completion Date :
Jan 28, 2021
Actual Study Completion Date :
Jan 28, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Local exercise therapy

The local exercise therapy group focused on strengthening knee and hip muscles three times a week for 6 weeks. Once a week, patients trained with the support of a physiotherapist. The physiotherapist gradually increased the intensity of the exercises improving muscle endurance. The exercises were supplemented with mobilisations of the patellofemoral joint. Twice a week, patients trained at home following a prescribed exercise program writing down their work-out in an exercise journal.

Procedure: Local exercise therapy
The local exercise therapy group will focus on strengthening knee and hip muscles three times a week for 6 weeks. Once a week, patients will train with the support of a physiotherapist. The physiotherapist gradually increases the intensity of the exercises improving muscle endurance. The exercises will be supplemented with mobilisations of the patellofemoral joint. Twice a week, patients train at home following a prescribed exercise program writing down their work-out in an exercise journal.

Experimental: Spinal manual therapy

The spinal manual therapy group was treated one a week for 6 weeks. Before the first intervention an experienced manual therapist performed a clinical examination of the lower back, SIJ, hip and knee. Anatomical maps showing innervation areas of spinal nerve roots were used to explain the regional interdependence model in the treatment of anterior knee pain. Manual therapy treatment included manipulations of the thoracolumbar (T12-L3) region or SIJ as well as hip joint. Manipulation was conducted if a restriction of range of motion was found in any of the regions. Patients were also asked to do home exercises focusing on mobilizing the thoracolumbar region and to write down their performance in an exercise journal.

Procedure: Spinal manual therapy
The spinal manual therapy group will be treated one a week for 6 weeks. Before the first intervention an experienced manual therapist performed a clinical examination of the lower back, SIJ, hip and knee. Anatomical maps showing innervation areas of spinal nerve roots will be used to explain the regional interdependence model in the treatment of anterior knee pain. Manual therapy treatment will include manipulations of the thoracolumbar (T12-L3) region or SIJ as well as hip joint. Manipulation will be conducted if a restriction of range of motion will be found in any of the regions. Patients will also be asked to do home exercises focusing on mobilizing the thoracolumbar region and to write down their performance in an exercise journal.

Outcome Measures

Primary Outcome Measures

  1. Visual analogue scale [before the first intervention (at baseline)]

    Maximum, minimum and current pain intensity was indicated on a 0-100 mm VAS line.

  2. Visual analogue scale [6 weeks after the first intervention (at 6 weeks)]

    Maximum, minimum and current pain intensity was indicated on a 0-100 mm VAS line.

  3. Visual analogue scale [6 weeks after the last intervention (at 12 weeks)]

    Maximum, minimum and current pain intensity was indicated on a 0-100 mm VAS line.

  4. Functionality [before the first intervention (baseline)]

    Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100

  5. Functionality [6 weeks after the first intervention (at 6 weeks)]

    Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100

  6. Functionality [6 weeks after the last intervention (at 12 weeks)]

    Functionality will be measured using the Dutch version of the anterior knee pain scale (AKPS). The AKPS questionnaire consists of 13 items assessing subjective symptoms and functional limitations totalling a maximum score of 100

Secondary Outcome Measures

  1. Knee extension strength [before the first intervention (baseline)]

    Maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings.

  2. Knee extension strength [6 weeks after the first intervention (at 6 weeks)]

    Maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings.

  3. Knee extension strength [6 weeks after the last intervention (at 12 weeks)]

    Maximum voluntary peak force (MVPF) of the quadriceps, will be measured using a Biodex system 3 isokinetic dynamometer (Biodex Medical Systems, Inc., Shirley, NY, USA). This system has shown sufficient reliability and validity for position, torque and velocity measurements in clinical and research settings.

Other Outcome Measures

  1. Age [before intervention (at baseline)]

    self-reported age (in years)

  2. Weight [before intervention (at baseline)]

    self-reported weight (in kg)

  3. Height [before intervention (at baseline)]

    self-reported height (in cm)

  4. Duration of symptoms [before intervention (at baseline)]

    self-reported duration of symptoms (in months)

  5. Sport [before intervention (at baseline)]

    self-reported weekly participation in sport (Yes/No)

  6. Previous exercise therapy [before intervention (at baseline)]

    self-reported previous exercise therapy treatment for the knee (Yes/No).

  7. Chondral lesion [before intervention (at baseline)]

    Grade of patellofemoral chondral lesion (Grade 0, Grade 1, Grade 2) using Kellgren and Lawrence system for classification of osteoarthritis (X-ray)

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • self-reported unilateral or

  • bilateral anterior knee pain provoked by at least two of the following activities: jumping, squatting, ascending/ descending stairs, kneeling, prolonged sitting and or a

  • positive patellar compression test

Exclusion Criteria:
  • experiencing pain for less than 3 months

  • a history of knee surgery

  • meniscal lesion

  • patellar subluxation/dislocation

  • evidence of tendinopathy or ligamentous pathologies

  • dislocation or fracture in the pelvic region

  • spinal surgery

  • osteoporosis

  • pregnancy

  • neurologic disorders

  • findings of chondromalacia > grade 2 on MRI, echography or X-ray.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Vrije Universiteit Brussel
  • VU University of Amsterdam

Investigators

  • Study Chair: Aldo Scafoglieri, Professor, Vrije Universiteit Brussel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Scafoglieri Aldo, Prof. dr. Aldo Scafoglieri, Vrije Universiteit Brussel
ClinicalTrials.gov Identifier:
NCT04748692
Other Study ID Numbers:
  • NL57207.096.16
First Posted:
Feb 10, 2021
Last Update Posted:
May 10, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Scafoglieri Aldo, Prof. dr. Aldo Scafoglieri, Vrije Universiteit Brussel
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 10, 2021